H
Loading...
Loading...
Growth-factor therapy on this site means concentrated signaling proteins from PRP and/or matrix-bound factors in tissue allografts. Name the source. Do not advertise a vague “growth factor drug.”
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18.
Growth factor therapy products for tissue repair and regeneration. Concentrated healing factors from PRP and tissue allografts. For healthcare providers nationwide.
Say the source. PRP = autologous. Allograft matrix = donor tissue with native factors. A compounded “growth factor drug” is a different object. Name it on the website the same way you will name it on the claim.
The human body relies on specific growth factors to orchestrate the healing process. Platelet-derived growth factor (PDGF) stimulates cell proliferation and collagen production. Transforming growth factor beta (TGF-β) regulates cell differentiation and extracellular matrix formation. Vascular endothelial growth factor (VEGF) promotes new blood vessel formation at injury sites. Fibroblast growth factor (FGF) supports wound healing and tissue regeneration. In concentrated form—whether from PRP or tissue allografts—these growth factors accelerate the body's natural repair mechanisms beyond what occurs through normal healing alone.
PRP therapy concentrates autologous growth factors from the patient's own blood, typically achieving 3-5x baseline platelet concentration with our 1-minute spin systems. This approach eliminates donor tissue concerns and provides a same-day treatment option. Tissue allografts—including umbilical cord tissue and amniotic membrane—contain a broader spectrum of growth factors, cytokines, and extracellular matrix components. They provide structural scaffolding alongside the biological signals. The right choice depends on the clinical application: PRP for orthopedic and soft tissue injuries, tissue allografts for wound care and complex tissue repair, or combination approaches for challenging cases.
Adding growth factor therapy to your clinical offerings requires the right equipment, products, and training. For PRP-based growth factor therapy, our systems require minimal setup—a standard blood draw, a 1-minute centrifuge spin, and a straightforward injection protocol. For tissue allograft growth factors, we provide product selection guidance based on clinical indication, proper handling and storage protocols, and the compliance documentation required for HCT/P regulated products. Both pathways create billable service lines that address real patient needs with biologically supported approaches to tissue repair.
PRP is autologous. Allograft matrix carries native factors in a 361 lane. A compounded ‘growth factor drug’ is a different regulatory object. Mixing those sentences is how warning letters start.
PDGF, TGF-β, and VEGF appear in literature. Your fee ticket still has to match the device or tissue IFU, not a blog citation.
PRP = autologous. Allograft = donor matrix with native factors. Different paperwork.
Described in literature; your claim should still match the IFU.
These SKUs are devices/tissue, not a separately approved growth-factor drug, unless a specific SKU says otherwise.
Yes for preparation and documentation.
Contact us today to learn how Hawk Medical can support your practice.
We're not just a distributor - we're healthcare providers who understand your challenges
We own and operate medical clinics, so we understand your real-world challenges
All products meet strict regulatory requirements including HCT/P 361 compliance
Personal account management and ongoing training for your entire team
10+ years of experience helping practices implement successful programs
Learn more about related treatments, solutions, and resources
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.